Envestnet Portfolio Solutions Inc. Sells 14,359 Shares of GE HealthCare Technologies Inc. $GEHC

Envestnet Portfolio Solutions Inc. trimmed its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 36.6% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 24,835 shares of the company’s stock after selling 14,359 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in GE HealthCare Technologies were worth $1,865,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. Allianz SE raised its stake in shares of GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock worth $26,000 after acquiring an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. grew its stake in shares of GE HealthCare Technologies by 130.7% during the third quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock valued at $26,000 after purchasing an additional 196 shares during the last quarter. Godsey & Gibb Inc. acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at approximately $26,000. Gladwyn Financial Advisors Inc. bought a new position in GE HealthCare Technologies in the 2nd quarter worth approximately $34,000. Finally, Piscataqua Savings Bank lifted its holdings in GE HealthCare Technologies by 173.4% during the 3rd quarter. Piscataqua Savings Bank now owns 473 shares of the company’s stock worth $36,000 after buying an additional 300 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Weiss Ratings restated a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Morgan Stanley boosted their price objective on GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Wells Fargo & Company cut their target price on shares of GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a research report on Thursday, October 30th. Evercore ISI reiterated an “outperform” rating and set a $95.00 price target on shares of GE HealthCare Technologies in a research report on Monday, January 5th. Finally, Stifel Nicolaus increased their price objective on shares of GE HealthCare Technologies from $90.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, January 7th. Seven analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $89.83.

GE HealthCare Technologies Price Performance

GEHC opened at $80.27 on Tuesday. The stock has a market cap of $36.56 billion, a P/E ratio of 16.58, a P/E/G ratio of 2.41 and a beta of 1.08. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The company has a quick ratio of 0.95, a current ratio of 1.18 and a debt-to-equity ratio of 0.83. The company has a fifty day simple moving average of $82.17 and a 200 day simple moving average of $77.26.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm had revenue of $5.14 billion during the quarter, compared to analysts’ expectations of $5.07 billion. During the same period in the previous year, the firm earned $1.14 earnings per share. The company’s revenue was up 5.8% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, research analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Friday, January 9th. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.